/
Azo & Formaldehyde Testing/
OECD 429 In Vivo Skin Sensitization TestingOECD 429 In Vivo Skin Sensitization Testing: Eurolabs Laboratory Testing Services
Standard-Related Information
The OECD 429 In Vivo Skin Sensitization Testing is a widely accepted laboratory test for assessing the skin sensitization potential of chemicals and materials. This test is governed by various international and national standards, including ISO 10993-10, ASTM F2425, EN ISO 10993-10, and TSE ISO 10993-10.
The legal and regulatory framework surrounding this testing service is outlined in the EUs Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation, as well as various industry-specific regulations such as the EU Cosmetics Regulation and the EU Biocidal Products Regulation.
In addition to these standards, Eurolab adheres to international standards for laboratory testing, including ISO 17025, which ensures that our testing services are performed in accordance with good laboratory practice (GLP) principles.
Standard Requirements and Needs
OECD 429 In Vivo Skin Sensitization Testing is required by various industries, including cosmetics, personal care products, pharmaceuticals, and biocides. This test is essential for ensuring the safety of products that come into contact with human skin.
The consequences of not performing this test can be severe, including product recalls, loss of market share, and damage to reputation. In addition, failure to comply with regulatory requirements can result in significant fines and penalties.
Test Conditions and Methodology
The OECD 429 In Vivo Skin Sensitization Testing is conducted using a combination of scientific expertise and state-of-the-art equipment. The test involves applying the test substance to the skin of mice or guinea pigs and assessing the local lymph node assay (LLNA) response.
The testing parameters and conditions are as follows:
The test is conducted in compliance with the OECD Guideline for the Testing of Chemicals No. 429.
Test Reporting and Documentation
Eurolabs reporting system includes a detailed report format that outlines the testing parameters, results, and conclusions. The report includes:
The test results are interpreted in accordance with the OECD Guideline for the Testing of Chemicals No. 429.
Why This Test Should Be Performed
Performing OECD 429 In Vivo Skin Sensitization Testing offers numerous benefits, including:
Why Eurolab Should Provide This Service
Eurolabs expertise and experience in OECD 429 In Vivo Skin Sensitization Testing make us the ideal partner for your laboratory testing needs. Our state-of-the-art equipment, qualified personnel, and adherence to international standards ensure that our testing services are of the highest quality.
Additional Requirements
Eurolabs comprehensive service includes:
Customer Testimonials
We were impressed by Eurolabs expertise in OECD 429 In Vivo Skin Sensitization Testing. Their report was clear, concise, and easy to understand. - Jane Doe, Regulatory Compliance Officer
I have been working with Eurolab for several years, and their laboratory testing services are always of the highest quality. - John Smith, Quality Manager
Industry-Specific Examples and Case Studies
Eurolab has extensive experience in OECD 429 In Vivo Skin Sensitization Testing across various industries, including:
Conclusion
OECD 429 In Vivo Skin Sensitization Testing is a critical laboratory test that ensures the safety and regulatory compliance of products that come into contact with human skin. Eurolabs comprehensive service, including technical support, sample preparation, data interpretation, and reporting, makes us the ideal partner for your laboratory testing needs.
References
1. OECD Guideline for the Testing of Chemicals No. 429: Skin Sensitisation: In Vitro Methods.
2. ISO 10993-10: Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization.
3. ASTM F2425: Standard Practice for Assessment of Skin Irritation/Redness Potential of Materials.
Appendix
Tables and figures illustrating the OECD 429 In Vivo Skin Sensitization Testing protocol are included in the appendix.